Common Stock Warrants |
12) Common Stock Warrants Upon the consummation of the Merger as disclosed in Note 1, Neurotrope warrants issued and outstanding as of December 1, 2020 were converted into equivalent warrants to purchase common stock of Petros and were adjusted to give effect to the Exchange Ratio set forth in the Merger Agreement. The following is a summary of warrants for the three months ended June 30, 2021: | | | | | Number of Shares | Warrants outstanding at December 31, 2020 | | 4,407,962 | Warrants issued | | — | Warrants exercised | | — | Warrants outstanding at June 30, 2021 | | 4,407,962 |
As of June 30, 2021, the Company’s warrants by expiration date were as follows: | | | | | | Number of Warrants | | Exercise Price | | Expiration Date | 76,569 | | $ | 32.00 | | November 17, 2021 | 131,344 | | | 64.00 | | November 17, 2021 | 2,780 | | | 1.60 | | August 23, 2023 | 18,000 | | | 35.65 | | June 1, 2024 | 4,800 | | | 35.60 | | June 5, 2024 | 74,864 | | | 21.85 | | June 17, 2024 | 20,043 | | | 31.25 | | June 19, 2024 | 22,800 | | | 26.55 | | September 1, 2024 | 10,500 | | | 12.74 | | September 16, 2024 | 22,800 | | | 4.30 | | December 1, 2024 | 28,000 | | | 5.65 | | March 2, 2025 | 28,000 | | | 7.30 | | June 1, 2025 | 28,000 | | | 5.50 | | September 1, 2025 | 28,000 | | | 4.71 | | December 1, 2025 | 2,221,829 | | | 7.50 | | December 1, 2025 | 908,498 | | | 17.50 | | December 1, 2025 | 623,303 | | | 51.25 | | December 1, 2025 | 157,832 | | | 125.00 | | December 1, 2025 | 4,407,962 | | | | | |
|